Research Solutions, Inc.

Name: Research Solutions, Inc. standardized financial statements, quarterly
Creator: Listed

RSSSNasdaqCIK 1386301IndustrialsFiscal year ends Jun 30

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$12.1m, Q4 FY2026

Operating income$842.4k, Q4 FY2026

Net income$665.6k, Q4 FY2026

Research Solutions, Inc., income statement, quarterly
Line item	Unit	Q1 FY20242023-09-30	Q2 FY20242023-12-31	Q3 FY20242024-03-31	Q4 FY20242024-06-30	Q1 FY20252024-09-30	Q2 FY20252024-12-31	Q3 FY20252025-03-31	Q4 FY20252025-06-30	Q1 FY20262025-09-30	Q2 FY20262025-12-31	Q3 FY20262026-03-31	Q4 FY20262026-06-30
Revenue	$m	10.1	10.3	12.1	12.1	12.0	11.9	12.7	12.4	12.3	11.8	12.1	12.1
Cost of revenue	$m	6.0	5.8	6.6	6.5	6.3	6.1	6.4	6.1	6.1	5.6	5.9	5.7
Gross profit	$m	4.0	4.5	5.5	5.6	5.8	5.8	6.3	6.3	6.2	6.2	6.3	6.4
Selling, general and administrative	$m	5.1	4.7	5.1	4.7	4.8	5.4	5.4	4.8	4.9	5.1	4.9	5.3
Operating income	$m	(1.1)	(0.4)	0.1	0.7	0.6	0.1	0.6	1.2	1.0	0.7	1.0	0.8
Interest expense	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Income tax	$m	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
Net income	$m	(1.0)	(0.1)	0.1	(2.8)	0.7	(2.0)	0.2	2.4	0.7	0.5	0.9	0.7
Diluted EPS	$ per share	(0.04)	0.00	0.00	not reported	0.02	(0.07)	0.01	not reported	0.02	0.02	0.03	not reported
Basic EPS	$ per share	(0.04)	0.00	0.00	not reported	0.02	(0.07)	0.01	not reported	0.02	0.02	0.03	not reported

Balance sheet

Cash and equivalents$12.6m, FY2026

Shareholders' equity$20.7m, FY2026

Research Solutions, Inc., balance sheet, quarterly
Line item	Unit	Q1 FY20242023-09-30	Q2 FY20242023-12-31	Q3 FY20242024-03-31	FY20242024-06-30	Q1 FY20252024-09-30	Q2 FY20252024-12-31	Q3 FY20252025-03-31	FY20252025-06-30	Q1 FY20262025-09-30	Q2 FY20262025-12-31	Q3 FY20262026-03-31	FY20262026-06-30
Cash and equivalents	$m	9.9	2.7	4.2	6.1	6.9	7.7	9.9	12.2	12.0	12.3	12.1	12.6
Current assets	$m	17.8	11.6	13.2	14.7	14.4	16.1	18.8	20.0	19.7	18.7	20.7	20.7
Total assets	$m	23.7	39.5	40.8	41.9	41.4	42.8	45.2	46.1	45.5	44.2	45.9	45.7
Current liabilities	$m	14.9	16.7	17.9	17.9	16.3	20.9	24.9	25.5	24.9	23.6	25.1	24.9
Total liabilities	$m	16.8	25.5	26.7	30.2	28.6	31.7	34.0	32.2	29.9	27.0	26.9	25.0
Shareholders' equity	$m	6.9	14.0	14.1	11.7	12.8	11.1	11.2	13.9	15.6	17.2	19.1	20.7

Cash flow

Operating cash flow$1.8m, Q4 FY2026

Capital expenditure$11.2k, Q4 FY2026

Share repurchases$5.7k, Q4 FY2026

Research Solutions, Inc., cash flow, quarterly
Line item	Unit	Q1 FY20242023-09-30	Q2 FY20242023-12-31	Q3 FY20242024-03-31	Q4 FY20242024-06-30	Q1 FY20252024-09-30	Q2 FY20252024-12-31	Q3 FY20252025-03-31	Q4 FY20252025-06-30	Q1 FY20262025-09-30	Q2 FY20262025-12-31	Q3 FY20262026-03-31	Q4 FY20262026-06-30
Operating cash flow	$k	(756)	329	2,017	1,961	843	1,028	2,893	2,259	1,107	1,384	1,008	1,775
Capital expenditure	$k	33.8	21.9	2.0	13.7	not reported	not reported	6.2	7.7	17.5	7.0	4.0	11.2
Share repurchases	$k	46.1	22.6	453	32.2	16.1	189	703	26.2	23.4	16.2	7.8	5.7

Diluted shares (weighted)32.44m, Q3 FY2026

Research Solutions, Inc., shares, quarterly
Line item	Unit	Q1 FY20232022-09-30	Q2 FY20232022-12-31	Q3 FY20232023-03-31	Q1 FY20242023-09-30	Q2 FY20242023-12-31	Q3 FY20242024-03-31	Q1 FY20252024-09-30	Q2 FY20252024-12-31	Q3 FY20252025-03-31	Q1 FY20262025-09-30	Q2 FY20262025-12-31	Q3 FY20262026-03-31
Diluted shares (weighted)	m shares	27.8	26.8	29.8	27.1	28.1	33.5	31.2	30.4	32.1	32.1	32.3	32.4

Shares outstanding: 33.76m at Sep 4, 2026, from the cover of the 10-K filed Sep 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. Listed shows no prices and gives no investment advice.